 Single center experience effect delayed function outcome retransplant recipients cadaveric renal allografts incidence DRF regraft study group patients historic high level HLA sensitization Primary NF immune event third regrafts Delayed use CyA ALG induction coverage good graft survival double triple maintenance therapy Stricter patient selection third transplants aggressive clinical monitoring regrafted patient actuarial graft survival result transplant center